Double Digit NASDAQ Stock Winners: XBIO, NTEC, NAOV
8:58 am Friday, July 30th, 2021
Following are major stock gainers on Nasdaq in Thursday’s trading session:
Xenetic Biosciences, Inc. (NASDAQ:XBIO) was the active stock gainer on Thursday and soared 65% to $5.30. The company announced the closing of its previously announced private placement with a single healthcare-focused institutional investor for 4,629,630 shares of its common stock (or common stock equivalents) at a purchase price per share of $2.70, priced at-the-market under Nasdaq rules. The gross proceeds to Xenetic totaled approximately $12.5 million before deducting placement agent fees and other offering expenses.
Intec Pharma Ltd (NASDAQ:NTEC) was another notable winner as the stock went up 48% to end the session at $13.56. The company entered into a securities purchase agreement with a single, healthcare-focused institutional investor to raise $30 million in a private placement. The private placement is being consummated to satisfy one of the closing conditions of the previously announced reverse merger with Decoy Biosystems, Inc. (the “Decoy Merger”).
NanoVibronix, Inc. (NASDAQ:NAOV) surged 26% to $2.41. The company announced that the Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutic Devices, has granted approval for its UroShield to be used by patients in Australia. In addition, the Company also announced that it has signed an agreement with DukeHill Healthcare Pty Ltd (DukeHill HC) to distribute the Company’s UroShield® and PainShield® technologies in Australia.
